Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Infection and Drug Resistance|October 2, 2019
Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwideRuihong Wu, Dongfeng Geng, Xiumei Chi, et al.
BMJ Open|August 21, 2019
Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational studyMingyuan Zhang, Ruihong Wu, Hongqin Xu, et al.
Scientific Reports|May 17, 2018
Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-upJing Wu, Shumei He, Hongqin Xu, et al.
Journal of Gastroenterology and Hepatology|January 12, 2016
Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patientsRuqi Mei, Xiumei Chi, Ruihong Wu, et al.
Scientific Reports|February 15, 2019
Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKDHui Zhang, Hongqin Xu, Ruihong Wu, et al.
Journal of Hepatocellular Carcinoma|October 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese PatientsMiaoxia Liu, Ruihong Wu, Xu Liu, et al.
Virology Journal|February 2, 2020
Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infectionLili Liu, Mingyuan Zhang, Lei Hang, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 29, 2016
IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infectionRuihong Wu, Xiumei Chi, Xiaomei Wang, et al.
BMC Public Health|September 21, 2015
Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in ChinaHongqin Xu, Ge Yu, Haibo Sun, et al.
Journal of Viral Hepatitis|September 19, 2023
Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-upHua He, Yanhua Wu, Zhifang Jia, et al.
Pageof 7